Legend Biotech (LEGN)

• Market cap: $5.25B
• 1 day: -0.84%
• 5 days: 1.65%
• 1 month: 19.95%
• 3 months: 53.25%
• 6 months: 1.98%
• Year to date: 31.38%
• 1 year: -0.11%
• 5 years: -28.22%
• 10 years: -23.62%
• Sector: Healthcare
• Industry: Biotechnology

About: Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Employees: 2,900